CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...
Stem cells hold immense potential in research and therapeutic development. One area where they are being utilized is in the development of advanced cell models, such as organoids. Stem cell-derived ...